Skip to main navigation Skip to search Skip to main content

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

  • Yoon Koo Kang
  • , Jeong Hwan Yook
  • , Young Kyu Park
  • , Jong Seok Lee
  • , Young Woo Kim
  • , Jin Young Kim
  • , Min Hee Ryu
  • , Sun Young Rha
  • , Ik Joo Chung
  • , In Ho Kim
  • , Sang Cheul Oh
  • , Young Soo Park
  • , Taeil Son
  • , Mi Ran Jung
  • , Mi Hwa Heo
  • , Hark Kyun Kim
  • , Cho Hyun Park
  • , Chang Hak Yoo
  • , Jin Hyuk Choi
  • , Dae Young Zang
    • You Jin Jang, Ji Young Sul, Jong Gwang Kim, Beom Su Kim, Seung Hoon Beom, Sang Hee Cho, Seung Wan Ryu, Myeong Cherl Kook, Baek Yeol Ryoo, Hyun Ki Kim, Moon Won Yoo, Nam Su Lee, Sang Ho Lee, Gyunji Kim, Yeon Ju Lee, Jee Hyun Lee, Sung Hoon Noh
  • University of Ulsan
  • Chonnam National University
  • National Cancer Center Korea
  • Keimyung University
  • Yonsei University
  • The Catholic University of Korea
  • Korea University
  • Sungkyunkwan University
  • Ajou University
  • Hallym University
  • Chungnam National University
  • Kyungpook National University
  • Soonchunhyang University
  • Kosin University
  • Sanofi-Aventis Korea

Research output: Contribution to journal › Article › peer-review

369   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science